SCHEMBL1596086

SCHEMBL1596086

[CH2]C(C)(C)COCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11552321 0.77
SCHEMBL21644983 0.75
SCHEMBL27262091 0.75 ALDH1A1 (0.30)
SCHEMBL9192589 0.73 ALDH1A1 (0.33)
SCHEMBL90144 0.73
SCHEMBL1276341 0.73 TSHR (0.40)
SCHEMBL4986973 0.73 ALDH1A1 (0.33)
SCHEMBL6668492 0.73
SCHEMBL9474158 0.73
SCHEMBL11551647 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105125599-B A kind of preparation method of the tribulus terrestris extraction containing total saponins of tribulus 内蒙古昶辉生物科技股份有限公司 2018-07-13 CN claimed
EP-0998454-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 2003-03-26 EP claimed
EP-0905126-B1 Metalloproteinase inhibitors BRITISH BIOTECH PHARM (GB) 2002-12-04 EP claimed
EP-0944587-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 2002-03-20 EP claimed
US-6358987-B1 FOR THERAPY AND PROPHYLAXIS OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL EPIDERMAL OR GASTRIC ULCERATION, AND TUMOUR METASTASIS, INVASION AND GROWTH BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2002-03-19 US claimed
US-6329373-B1 AMIDES WITH HYDROXYAMIDES AS ENZYME INHIBITORS BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2001-12-11 US claimed
EP-0873304-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 2001-09-05 EP claimed
US-6271262-B1 AMIDESULFONAMIDE COMPOUNDS AS ENZYME INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-08-07 US claimed
US-6258851-B1 ENZYME INHIBITORS OF PROTEASES OR METALLOENZYMES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-07-10 US claimed
US-6127427-A ACTIVE HYDROXAMIC ACIDS INVOLVED IN TISSUE DEGRADTION AND ALSO ARE INHIBITORS OF THE RELEASE OF TUMOUR NECROSIS FACTOR FROM CELLS; RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, VISION DEFECTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-10-03 US claimed
WO-1997019053-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-05-29 WO claimed
EP-0766664-A2 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-04-09 EP claimed
EP-0763012-A1 SUCCINYL HYDROXAMIC ACID, N-FORMYL-N-HYDROXY AMINO CARBOXYLIC ACID AND SUCCINIC ACID AMIDE DERIVATIVES AS METALLOPROTEASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-03-19 EP claimed
EP-0694036-B1 HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARM (GB) 1997-03-05 EP claimed
EP-0740655-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1996-11-06 EP claimed
EP-0694036-A1 HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARM (GB) 1996-01-31 EP claimed
WO-1995035275-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-12-28 WO claimed
WO-1995032944-A1 SUCCINYL HYDROXAMIC ACID, N-FORMYL-N-HYDROXY AMINO CARBOXYLIC ACID AND SUCCINIC ACID AMIDE DERIVATIVES AS METALLOPROTEASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-12-07 WO claimed
WO-1995019961-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-07-27 WO claimed
WO-1994024140-A1 HYDROXAMIC ACID DERIVATIVES BRITISH BIO-TECHNOLOGY LIMITED (GB) 1994-10-27 WO claimed